GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Nasdaq  -  04:00 2022-08-16 pm EDT
66.33 USD   +0.18%
08/16Gilead Sciences Says Veklury Demonstrates Continued In Vitro Antiviral Activity Against Omicron
MT
08/16Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency
AQ
08/16Everest Medicines Terminates Cancer Drug Licensing Deal with Immunomedics
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about GILEAD SCIENCES, INC.
08/16Gilead Sciences Says Veklury Demonstrates Continued In Vitro Antiviral Activity Against..
MT
08/16Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobili..
AQ
08/16Everest Medicines Terminates Cancer Drug Licensing Deal with Immunomedics
MT
08/16Gilead to Acquire Remaining Worldwide Rights of Trodelvy
AQ
08/16Gilead Sciences Unit Enters Into Licensing Agreement With Everest Medicines for Trodelv..
MT
08/15Gilead to Acquire Remaining Worldwide Rights of Trodelvy«
BU
08/15US Stocks Start Week Higher as Tesla Helps Lift Tech Sector
MT
08/15US Stocks Start Week Higher as Tech, Megacap Growth Stocks Gain
MT
08/15Unity Software, Turquoise Hill fall; Gilead, Moderna rise
AQ
08/15Health Care Up as Gilead Rallies on Cancer-Drug Hopes -- Health Care Roundup
DJ
08/15Gilead's Trodelvy 'Significantly Improves' Overall Survival in Pre-Treated Metastatic B..
MT
08/15Top Midday Gainers
MT
08/15MIDDAY REPORT : US Equity Indices Claw Back Losses While Treasury Yields Drop; China July ..
MT
08/15Gilead Sciences on Pace for Largest Percent Increase Since January 2021 -- Data Talk
DJ
08/15Gilead's Trodelvy 'Significantly Improves' Overall Survival in Pre-Treated Metastatic B..
MT
08/15Piper Sandler Adjusts Gilead Sciences' Price Target to $74 From $71, Maintains Neutral ..
MT
08/15Gilead Sciences Shares Spike Premarket, Trodelvy 'Significantly' Improves Overall Survi..
MT
08/15Trodelvy« Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic B..
BU
08/15Gilead Sciences, Inc. Announces Trodelvy« Significantly Improves Overall Survival in Pr..
CI
08/09Few U.S. patients with hepatitis C get timely treatment, CDC says
RE
08/09Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups
RE
08/09Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobili..
BU
08/05OXFORD UNIVERSITY : Oxford spinout MiroBio acquired by Gilead Sciences for $405m
AQ
08/04UBS Adjusts Gilead Sciences Price Target to $65 From $63, Maintains Neutral Rating
MT
08/04Gilead Sciences to Buy UK Biotech Firm MiroBio for $405 Million
MT
08/04Gilead Sciences to Acquire MiroBio
BU
08/04Gilead Sciences, Inc. entered into a definitive agreement to acquire MiroBio Ltd from S..
CI
08/03Health Care Up After Moderna, CVS Earnings -- Health Care Roundup
DJ
08/03GLOBAL MARKETS LIVE : Airbnb, Infineon, PayPal, Moderna, Starbucks...
MS
08/03Gilead Sciences Up Over 5%, on Pace for Largest Percent Increase Since January 2021 -- ..
DJ
08/03WALL STREET STOCK EXCHANGE : A couple of hopes dashed
MS
08/02Gilead sciences exec says more of a positive impact to hiv busin…
RE
08/02Gilead sciences exec says negotiation part of drug pricing propo…
RE
08/02Gilead sciences exec says expect continued foreign exchange head…
RE
08/02Gilead Sciences Updates Fiscal Year Outlook Following 2Q Results
DJ
08/02Gilead sciences exec says veklury sales slowed with decline in h…
RE
08/02Gilead sciences exec says expecting fda decision on hiv treatmen…
RE
08/02Gilead Sciences Posts Slightly Higher 2Q Sales
DJ
08/02Gilead quarterly profit falls as COVID antiviral sales decrease
RE
08/02TRANSCRIPT : Gilead Sciences, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02GILEAD : Q2 Earnings Snapshot
AQ
08/02Gilead Sciences Q2 Adjusted EPS Drop While Revenue Gains; Company Boosts 2022 Outlook
MT
08/02GILEAD SCIENCES : ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
08/02GILEAD SCIENCES : Q2 2022 Presentation
PU
08/02Gilead Sciences, Inc. Declares Quarterly Cash Dividend for the Third Quarter of 2022, P..
CI
08/02GUIDANCE : (GILD) GILEAD SCIENCES Sees Fiscal Year 2022 EPS Range $6.35 - $6.75
MT
08/02Earnings Flash (GILD) GILEAD SCIENCES Reports Q2 Revenue $6.26B
MT
08/02Earnings Flash (GILD) GILEAD SCIENCES Posts Q2 EPS $1.58
MT
08/02Gilead Sciences Announces Second Quarter 2022 Financial Results
BU
08/02Gilead Sciences, Inc. Revises Earnings Guidance for the Full Year 2022
CI
08/02Gilead Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/02EARNINGS REACTION HISTORY : Gilead Sciences, 63.6% Follow-Through Indicator, 3.0% Sensitiv..
MT
07/28Gilead Sciences, Inc. Announces Executive Changes
CI
07/28Gilead Sciences Says Biktarvy Treatment Shows Efficacy in Patients With HIV/Hepatitis B..
MT
07/28Biktarvy« Demonstrates High Efficacy for a Broad Range of People Initiating Treatment f..
BU
07/28Gilead Sciences, Inc. Announces Results Reinforcing Biktarvy
CI
07/28Cheap copies of GSK's HIV prevention drug could be ready in 2026
RE
07/28GILEAD SCIENCES : Statement on FDA Acceptance of New Drug Application for Investigational ..
PU
07/27GSK Banks on Vaccines, Specialty Medicines to Achieve Upgraded 2022 Targets Post-Haleon..
MT
07/26Piper Sandler Adjusts Price Target on Gilead Sciences to $71 From $69, Maintains Neutra..
MT
07/25Berkeley Lights Names Mehul Joshi Finance Chief
MT
07/25Kite's CAR T-cell Therapy Tecartus Receives Positive CHMP Opinion in Relapsed or Refrac..
AQ
07/25Gilead Sciences, Inc. - CHMP Adopts Positive Opinion Recommending Veklury (Remdesivir) ..
AQ
07/22Gilead Sciences Unit Receives Positive CHMP Opinion for Lymphoblastic Leukemia Treatmen..
MT
07/22Kite's CAR T-cell Therapy Tecartus« Receives Positive CHMP Opinion in Relapsed or Refra..
BU
07/22Gilead Sciences' Kite Unit Gets Positive CHMP Opinion for Tecartus
DJ
07/22Gilead Sciences' Treatment for COVID-19 Patients Veklury Receives Positive Opinion by C..
MT
07/22CHMP Adopts Positive Opinion Recommending Veklury« (Remdesivir) Receive Full Marketing ..
BU
07/22Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Gil..
CI
07/22GILEAD SCIENCES : CHMP Backs Full Marketing Authorization for Covid-19 Treatment
DJ
07/21Scientific Innovation and Collaboration Highlighted at AIDS 2022 as Gilead Extends Lead..
BU
07/20Gilead Sciences Contributes Additional $85 Million to Its Foundation to Advance Health ..
BU
07/20Gilead Sciences Contributes $85 Million to Foundation to Advance Health Equity
DJ
07/19Gilead Sciences Signs New Joint Procurement Agreement with the European Commission for ..
BU
07/19European Commission Signs Joint Procurement Framework For Gilead's Veklury
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
08/08Report 
08/08SEC Filing 10Q-2 
08/02SEC Filing 8K 
08/02Press Release 
08/02Half-year results 
07/26Report 
Upcoming event on GILEAD SCIENCES, INC.